GenTech(SH:688596)2020-10-29 16:00Financial Performance - Net profit attributable to shareholders increased by 260.07% to CNY 46,184,632.13 year-to-date[18] - Operating revenue decreased by 1.99% to CNY 675,176,558.24 year-to-date[18] - Basic earnings per share rose by 228.57% to CNY 0.23[21] - Total operating revenue for Q3 2020 was CNY 230,394,065.81, an increase from CNY 176,303,624.55 in Q3 2019, representing a growth of approximately 30.7%[54] - Net profit for Q3 2020 reached CNY 19,378,275.84, a significant recovery from a net loss of CNY 2,507,873.52 in Q3 2019[58] - The company reported a total comprehensive income of approximately ¥18.17 million for Q3 2020, compared to a loss of ¥0.80 million in the same period of 2019[61] - The basic and diluted earnings per share for Q3 2020 were both ¥0.09, compared to a loss of ¥0.013 per share in Q3 2019, indicating a return to profitability[61] Assets and Liabilities - Total assets increased by 44.93% to CNY 2,457,190,683.77 compared to the end of the previous year[18] - The company's total assets at the end of the reporting period were significantly impacted by the IPO, leading to a substantial increase in capital reserves by 358.13% to ¥1,082,848,715.19[31] - Total liabilities decreased to approximately ¥829.91 million from ¥1.03 billion, a reduction of about 19%[45] - The total liabilities amounted to CNY 807,270,442.92, down from CNY 959,296,334.63 in the previous reporting period[51] - The total equity increased to CNY 1,537,574,279.26, compared to CNY 587,152,804.45 previously, indicating a substantial growth in shareholder equity[51] Cash Flow - The company reported a net cash flow from operating activities of -CNY 117,389,414.13 year-to-date[18] - Net cash flow from financing activities increased by 1,050.82% to ¥754,662,357.35, mainly from funds raised during the IPO[33] - The net cash flow from operating activities for the first three quarters of 2020 was -117,389,414.13 RMB, compared to -28,835,685.62 RMB in the same period of 2019[70] - Cash inflow from financing activities was 1,012,218,305.31 RMB, significantly higher than 216,015,000.00 RMB in the previous year[70] Shareholder Information - The total number of shareholders at the end of the reporting period was 17,374[22] - The largest shareholder, Fengfan Holdings Limited, holds 20.78% of the shares[22] Research and Development - Research and development expenses accounted for 4.14% of operating revenue, a decrease of 0.55 percentage points[21] - Research and development expenses for Q3 2020 were CNY 9,190,044.47, a decrease from CNY 14,408,830.64 in Q3 2019, showing a reduction of approximately 36.5%[54] - Research and development expenses for Q3 2020 were approximately ¥5.43 million, a significant decrease from ¥11.44 million in Q3 2019, reflecting a strategic shift in resource allocation[62] Future Strategy - The company plans to focus on market expansion and new product development as part of its future strategy[54] - The company plans to expand its market presence and invest in new technologies to drive future growth, although specific figures were not disclosed during the call[62]